PROTECTION OF CYTOCHROME-C-OXIDASE AGAINST CYANIDE INHIBITION BY PYRUVATE AND ALPHA-KETOGLUTARATE - EFFECT OF AERATION IN-VITRO

被引:22
|
作者
DELHUMEAU, G [1 ]
CRUZMENDOZA, AM [1 ]
LOJERO, CG [1 ]
机构
[1] INST POLITECN NACL,CTR INVEST & ESTUDIOS AVANZADOS,MEXICO CITY 07000,DF,MEXICO
关键词
D O I
10.1006/taap.1994.1125
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Toxicity of cyanide is related to its inhibitory action on cytochrome c oxidase (COx). The alpha-keto acids pyruvate and alpha-ketoglutarate are known to exert in vivo certain protective effect against CN- toxicity if present when the poison is administered. We characterized in vitro their protection of oxidative phosphorylation and of the activity of COx in rat testis, heart, and liver mitochondria, as well as that of the beef heart enzyme in the pure state. In all cases the keto acids proved to have a protective action, even when KCN was previously added to the incubation mixtures and inhibition had already been established. However, the extent of the protection seemed to depend upon the degree of aeration. In the presence of the alpha-keto acids, O-2 succeeded with 77% efficiency in reversing CN- inhibition of [gamma(32)P]ATP synthesis under high aeration, whereas only 15% was achieved if aeration was poor. In poisoned heart mitochondria (1 mM KCN) simultaneous estimations of ATP synthesis and COx activity in a closed oxygraph chamber showed a recovery of only 6% of both activities upon the addition of 12 mM pyruvate. Our results suggest that O-2 displaced cyanide from the enzyme and the poison was then trapped by the keto acids to form the respective nontoxic cyanohydrin. The combination of both high oxygen concentration and the presence of either pyruvate or alpha-ketoglutarate was necessary to effectively protect COx against cyanide poisoning. (C) 1994 Academic Press, Inc.
引用
收藏
页码:345 / 351
页数:7
相关论文
共 13 条
  • [1] PROTECTION AGAINST CYANIDE-INDUCED CONVULSIONS WITH ALPHA-KETOGLUTARATE
    YAMAMOTO, HA
    TOXICOLOGY, 1990, 61 (03) : 221 - 228
  • [2] Reversal of cyanide inhibition of cytochrome c oxidase by pyruvate
    Nuskova, H.
    Pecinova, A.
    Pecina, P.
    Vrbacky, M.
    Drahota, Z.
    Houstek, J.
    FEBS JOURNAL, 2009, 276 : 215 - 215
  • [3] Cyanide inhibition and pyruvate-induced recovery of cytochrome c oxidase
    Hana Nůsková
    Marek Vrbacký
    Zdeněk Drahota
    Josef Houštěk
    Journal of Bioenergetics and Biomembranes, 2010, 42 : 395 - 403
  • [4] Cyanide inhibition and pyruvate-induced recovery of cytochrome c oxidase
    Nuskova, Hana
    Vrbacky, Marek
    Drahota, Zdenek
    Houstek, Josef
    JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2010, 42 (05) : 395 - 403
  • [5] Cyanide inhibition and pyruvate-induced recovery of cytochrome c oxidase
    Nuskova, Hana
    Vrbacky, Marek
    Drahota, Zdenek
    Houstek, Josef
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2010, 1797 : 99 - 99
  • [6] EFFECT OF HYDROXYCOBALAMIN ON INHIBITION OF CYTOCHROME-C OXIDASE BY CYANIDE .2. IN ISOLATED CYTOCHROME-C OXIDASE
    VIEIRALOPES, LC
    CAMPELLO, AP
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1976, 14 (01): : 177 - 191
  • [7] EFFECT OF METHEMOGLOBIN ON INHIBITION OF CYTOCHROME-C OXIDASE BY CYANIDE, SULFIDE OR AZIDE
    SMITH, L
    KRUSZYNA, H
    SMITH, RP
    BIOCHEMICAL PHARMACOLOGY, 1977, 26 (23) : 2247 - 2250
  • [8] EFFECT OF THE INTERNAL AQUEOUS PHASE PH AND MEMBRANE-POTENTIAL ON CYANIDE BINDING WITH CYTOCHROME-C-OXIDASE IN PROTEOLIPOSOMES
    VYGODINA, TV
    ANDREEV, IM
    KONSTANTINOV, AA
    BIOLOGICHESKIE MEMBRANY, 1986, 3 (06): : 563 - 574
  • [9] In-vitro and in-vivo functional observation studies to establish therapeutic potential of alpha-ketoglutarate against methotrexate induced liver injury
    Mehra, Lalita
    Bhattacharya, Aditi
    Rawat, Harish
    Kumar, Amit
    Jaimini, Abhinav
    Mittal, Gaurav
    BIOMEDICAL JOURNAL, 2021, 44 (05) : 611 - 619
  • [10] EFFECT OF HYDROXYCOBALAMIN ON INHIBITION OF CYTOCHROME-C OXIDASE BY CYANIDE .1. INTACT MITOCHONDRIA
    VIEIRALOPES, LC
    CAMPELLO, AP
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1975, 12 (03): : 521 - 532